Horizon Therapeutics Announces Significant Expansion and Relocation of U.S. Operations
January 28 2020 - 11:10AM
Business Wire
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it
has agreed to purchase the three-building campus in Deerfield that
formerly belonged to Takeda Pharmaceuticals. The transaction is
expected to close in the first quarter with additional terms of the
purchase not disclosed. Horizon is expected to occupy the campus in
the second half of this year.
“Lake County has a rich life sciences ecosystem and we are
looking forward to continuing to contribute to and lead the growth
of that ecosystem,” said Timothy Walbert, chairman, president and
chief executive officer. “We have experienced significant growth
during the last three years including adding more than 200
employees in 2019. This new campus gives us the flexibility to
accommodate our current employees as well as our anticipated
long-term growth.”
The Deerfield campus totals 70 acres and consists of more than
650,000 square feet of building space.
“Illinois’ biopharmaceutical industry has a deep talent pool,
and a bright future, and we’ll continue to invest in making sure
that this industry can continue to be a crucial job creation
engine, as well as developing treatments and potential cures for
patients locally and globally,” said Governor JB Pritzker. “I am
pleased to see the continued growth of Horizon Therapeutics and the
life-changing medicines the company is developing.”
“The Governor recognizes the importance of a health life
sciences sector, which is why it’s a critical part of the five-year
economic development plan,” said Acting Director of the Illinois
Department of Commerce and Economic Opportunity, Erin Guthrie.
“Seeing companies such as Horizon invest in its Illinois footprint
shows the progress that the State of Illinois has made and is a
testament to the strength of our people and our commitment to our
companies.”
“I am thrilled to welcome Horizon back to Deerfield,” said
Deerfield Mayor Harriet Rosenthal. “As mayor, it pleases me to see
the growth Horizon has achieved during its time in Lake County.
Horizon’s innovative spirit and its commitment to patients,
employees and the communities in which they live and work has been
extensively recognized. We welcome its deep community spirit to the
Village of Deerfield and look forward to a long and prosperous
relationship with Horizon and its employees.”
Horizon is being represented in the transaction by CBRE.
About Horizon
Horizon is focused on researching, developing and
commercializing medicines that address critical needs for people
impacted by rare and rheumatic diseases. Our pipeline is
purposeful: we apply scientific expertise and courage to bring
clinically meaningful therapies to patients. We believe science and
compassion must work together to transform lives. For more
information on how we go to incredible lengths to impact lives,
please visit www.horizontherapeutics.com, follow us @HorizonNews on
Twitter, like us on Facebook or explore career opportunities on
LinkedIn.
Forward Looking Statements
This press release contains forward-looking statements,
including, but not limited to, statements related to the timing of
closing the real estate transaction and Horizon’s relocation of its
U.S. operations, the potential benefits of the new U.S. operations,
potential future growth of Horizon’s business and employee base,
and other statements that are not historical facts. These
forward-looking statements are based on Horizon’s current
expectations and inherently involve significant risks and
uncertainties. Actual results and the timing of events could differ
materially from those anticipated in such forward-looking
statements as a result of these risks and uncertainties, which
include, without limitation, risks related to the satisfaction of
closing conditions related to the real estate transaction,
Horizon’s ability to grow sales and revenues from existing
medicines, Horizon’s ability to complete the planned relocation of
its U.S. operations on anticipated timelines, whether the new
facilities will be adequate for Horizon’s future needs, and those
risks detailed from time-to-time under the caption "Risk Factors"
and elsewhere in Horizon's filings and reports with the U.S.
Securities and Exchange Commission. Horizon undertakes no duty or
obligation to update any forward-looking statements contained in
this presentation as a result of new information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200128005606/en/
U.S. Media Contact: Geoff Curtis Executive Vice
President, Corporate Affairs and Chief Communications Officer
media@horizontherapeutics.com Investor Contacts: Tina
Ventura Senior Vice President, Investor Relations
Investor-relations@horizontherapeutics.com Ruth Venning
Executive Director, Investor Relations
Investor-relations@horizontherapeutics.com Ireland Media
Contact: Gordon MRM Ray Gordon ray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Sep 2023 to Sep 2024